1. Home
  2. OPTN vs RVPH Comparison

OPTN vs RVPH Comparison

Compare OPTN & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTN
  • RVPH
  • Stock Information
  • Founded
  • OPTN 2010
  • RVPH 2006
  • Country
  • OPTN United States
  • RVPH United States
  • Employees
  • OPTN N/A
  • RVPH N/A
  • Industry
  • OPTN Biotechnology: Pharmaceutical Preparations
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPTN Health Care
  • RVPH Health Care
  • Exchange
  • OPTN Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • OPTN 92.8M
  • RVPH N/A
  • IPO Year
  • OPTN 2017
  • RVPH N/A
  • Fundamental
  • Price
  • OPTN $9.39
  • RVPH $0.82
  • Analyst Decision
  • OPTN Hold
  • RVPH Strong Buy
  • Analyst Count
  • OPTN 3
  • RVPH 5
  • Target Price
  • OPTN $9.00
  • RVPH $10.00
  • AVG Volume (30 Days)
  • OPTN 41.7K
  • RVPH 470.8K
  • Earning Date
  • OPTN 05-20-2025
  • RVPH 05-20-2025
  • Dividend Yield
  • OPTN N/A
  • RVPH N/A
  • EPS Growth
  • OPTN N/A
  • RVPH N/A
  • EPS
  • OPTN N/A
  • RVPH N/A
  • Revenue
  • OPTN $78,226,000.00
  • RVPH N/A
  • Revenue This Year
  • OPTN $30.49
  • RVPH N/A
  • Revenue Next Year
  • OPTN $13.51
  • RVPH N/A
  • P/E Ratio
  • OPTN N/A
  • RVPH N/A
  • Revenue Growth
  • OPTN 10.20
  • RVPH N/A
  • 52 Week Low
  • OPTN $4.82
  • RVPH $0.49
  • 52 Week High
  • OPTN $20.03
  • RVPH $4.28
  • Technical
  • Relative Strength Index (RSI)
  • OPTN 76.15
  • RVPH 46.85
  • Support Level
  • OPTN $9.14
  • RVPH $0.83
  • Resistance Level
  • OPTN $9.45
  • RVPH $0.90
  • Average True Range (ATR)
  • OPTN 0.08
  • RVPH 0.07
  • MACD
  • OPTN -0.07
  • RVPH 0.01
  • Stochastic Oscillator
  • OPTN 80.71
  • RVPH 53.41

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

Share on Social Networks: